Current issues in the management of sinonasal methicillin-resistant Staphylococcus aureus

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 17, Issue 1, 2009, Pages 2-5

  Becker, Samuel S ^a   Russell, Paul T ^a   Duncavage, James A ^a   Creech, C Buddy ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Methicillin; Methicillin resistant Staphylococcus aureus; Sinusitis; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PARANASAL SINUS DISEASE; PRIORITY JOURNAL; REVIEW; RHINOSINUSITIS; SINUSITIS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WASTE MANAGEMENT; ADOLESCENT; CHILD; DRUG EFFECT; EVIDENCE BASED MEDICINE; FEMALE; HOSPITALIZATION; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SINUSITIS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 66149142832     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32831b9c97     Document Type: Review

References (32)

1. Buescher ES. Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics. Curr Opin Pediatr 2005; 17:67-70.
2. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001; 175:264-267. (Pubitemid 32851061)
3. National Public Radio News. Prevalence of MRSA 'superbug' sparks concern. 17 October 2007.
4. ABC News, 'Superbug' MRSA worries doctors, athletes. 13 January 2005.
5. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-520. (Pubitemid 27359263)
6. Nouwen JL, Ott A, Kluytmans-Vandenbergh MF, et al. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a 'culture rule'. Clin Infect Dis 2004; 39:806-811.
7. Nouwen JL, van Belkum A, Verbrugh HA. Determinants of Staphylococcus aureus nasal carriage. Neth J Med 2001; 59:126-133. (Pubitemid 32907200)
8. Mandell GL, Douglas RG, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005.
9. Creech CB 2nd, Kernodle DS, Alsentzer A, et al. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005; 24:617-621.
10. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community- acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40:1785-1791. (Pubitemid 40799948)
11. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, et al. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23:701-706. (Pubitemid 39063283)
12. Nakamura MM, Rohling KL, Shashaty M, et al. Prevalence of methicillinresistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J 2002; 21:917-922. (Pubitemid 35176150)
13. Chambers HF. Community-associated MRSA - resistance and virulence converge. N Engl J Med 2005; 352:1485-1487.
14. Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39:47-54. (Pubitemid 38879548)
15. Parras F, Guerrero MC, Bouza E, et al. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995; 39:175-179.
16. Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991; 114:101-106.
17. Alfaro C, Mascher-Denen M, Fergie J, Purcell K. Prevalence of methicillinresistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children's Hospital. Pediatr Infect Dis J 2006; 25:459-461. (Pubitemid 43755106)
18. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001- 2004. J Infect Dis 2008; 197:1226-1234. This article provides a focused review of microbial colonization during the study period described.
19. Brook I. The role of bacteria in chronic rhinosinusitis. Otolaryngol Clin North Am 2005; 38:1171-1192.
20. Nadel DM, Lanza DC, Kennedy DW. Endoscopically guided sinus cultures in normal subjects. Am J Rhinol 1999; 13:87-90.
21. Palmer JN. Bacterial biofilms: do they play a role in chronic rhinosinusitis. Otolaryngol Clin North Am 2005; 38:1193-1201. (Pubitemid 41737831)
22. Sieberling KA, Grammer L, Kern RC. Chronic rhinosinusitis and superantigens. Otolaryngol Clin North Am 2005; 38:1215-1236.
23. Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004; 114:1369-1375. (Pubitemid 39575892)
24. Mascia K, Borish L, Patrie J, et al. Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2005; 94:652-657. (Pubitemid 40847151)
25. Chan J, Hadley J. The microbiology of chronic rhinosinusitis: results of a community surveillance survey. Ear Nose Throat J 2001; 80:143-145. (Pubitemid 32221867)
26. Bhattacharyya N, Gopal HV, Lee KH. Bacterial infection after endoscopic sinus surgery: a controlled prospective study. Laryngoscope 2004; 114:765-767. (Pubitemid 38548794)
27. Gerencer RZ. Successful outpatient treatment of sinusitis exacerbations caused by community-acquired methicillin-resistant Staphylococcus aureus. Otolaryngol Head Neck Surg 2005; 132:828-833.
28. Jiang RS, Jang JW, Hsu CY. Postfunctional endoscopic sinus surgery methicillin-resistant Staphylococcus aureus sinusitis. Am J Rhinol 1999; 13:273-277.
29. Bhattacharyya N, Kepnes L. Assessment of trends in antimicrobial resistance in chronic rhinosinusitis. Ann Otol Rhinol Laryngol 2008; 117: 448-452. This article provides important insight into resistance patterns in patients with chronic sinusitis.
30. Faibis F, Laporte C, Fiacre A, et al. An outbreak of methicillin- resistant Staphylococcus aureus surgical site infections initiated by a healthcare worker with chronic sinusitis. Infect Control Hosp Epidemiol 2005; 26:213-215. (Pubitemid 40445028)
31. Tabaee A, Anand VK, Yoon C. Outpatient intravenous antibiotics for methicillin- resistant Staphylococcus aureus sinusitis. Am J Rhinol 2007; 21: 154-158. This article provides important data regarding the efficacy and morbidity of parenteral antibiotics for the treatment of MRSA sinusitis. (Pubitemid 46846343)
32. Doebbeling BN, Reagan DR, Pfaller MA, et al. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994; 154:1505-1508.